These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3040850)

  • 1. Treatment of pituitary macroadenomas secreting PRL, HGH or ACTH with long-acting bromocriptine.
    Halperin I; Rodriguez MD; Cardenal C; Casamitjana R; Martinez Osaba MJ; Lienas V; Vilardell E
    J Endocrinol Invest; 1987 Jun; 10(3):277-82. PubMed ID: 3040850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a long-acting injectable form of bromocriptine in patients with prolactin and growth hormone secreting macroadenomas.
    Tsagarakis S; Tsiganou E; Tzavara I; Nikolou H; Thalassinos N
    Clin Endocrinol (Oxf); 1995 Jun; 42(6):593-9. PubMed ID: 7634499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of a single injectable dose of bromocriptine long acting in the treatment of macroprolactinomas.
    Schettini G; Lombardi G; Merola B; Miletto P; Fariello C; Cirillo S; Fusco R; Lancranjan I
    J Endocrinol Invest; 1988 Jan; 11(1):47-51. PubMed ID: 3361075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of prolactinomas and growth hormone-producing adenomas with an injectable bromocriptine retard preparation and a somatostatin analogue delivered by an implantable pump.
    Schatz H; Stracke H; Hildebrandt G
    Pathol Res Pract; 1988 Sep; 183(5):546-51. PubMed ID: 3237541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bromocriptine treatment of pituitary adenomas. Evaluation of withdrawal effect.
    Coculescu M; Simionescu N; Oprescu M; Alessandrescu D
    Endocrinologie; 1983; 21(3):157-68. PubMed ID: 6635518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A long-acting repeatable form of bromocriptine as long-term treatment of prolactin-secreting macroadenomas: a multicenter study.
    Brue T; Lancranjan I; Louvet JP; Dewailly D; Roger P; Jaquet P
    Fertil Steril; 1992 Jan; 57(1):74-80. PubMed ID: 1730334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tamoxifen on GH and PRL secretion by human pituitary tumors.
    Lamberts SW; de Quijada M; Klijn JG
    J Endocrinol Invest; 1980; 3(4):343-7. PubMed ID: 7204884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-lasting suppression of prolactin secretion and rapid shrinkage of prolactinomas after a long-acting, injectable form of bromocriptine.
    Montini M; Pagani G; Gianola D; Pagani MD; Salmoiraghi M; Ferrari L; Lancranjan I
    J Clin Endocrinol Metab; 1986 Jul; 63(1):266-8. PubMed ID: 3711262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study.
    Molitch ME; Elton RL; Blackwell RE; Caldwell B; Chang RJ; Jaffe R; Joplin G; Robbins RJ; Tyson J; Thorner MO
    J Clin Endocrinol Metab; 1985 Apr; 60(4):698-705. PubMed ID: 3882737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-acting injectable bromocriptine (Parlodel LAR) in the chronic treatment of prolactin-secreting macroadenomas.
    Lengyel AM; Mussio W; Imamura P; Vieira JG; Lancranjan I
    Fertil Steril; 1993 May; 59(5):980-7. PubMed ID: 8486199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bromocriptine treatment on the fibrous tissue content of prolactin-secreting and nonfunctioning macroadenomas of the pituitary gland.
    Esiri MM; Bevan JS; Burke CW; Adams CB
    J Clin Endocrinol Metab; 1986 Aug; 63(2):383-8. PubMed ID: 3722328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The medical management of hormone-secreting tumors of the pituitary.
    Wass JA; Besser GM
    Annu Rev Med; 1983; 34():283-94. PubMed ID: 6305258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of Parlodel-LAR and response to long-term treatment with bromocriptine in a patient with a follicle stimulating hormone-secreting pituitary adenoma.
    Abs R; Parizel PM; Beckers A
    J Endocrinol Invest; 1991 Feb; 14(2):135-8. PubMed ID: 1905737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of prolactin-secreting macroadenomas with parenteral, long-acting bromocriptine in 30 patients treated for up to 3 years.
    Haase R; Jaspers C; Schulte HM; Lancranja I; Pfingsten H; Orri-Fend M; Reinwein D; Benker G
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):165-76. PubMed ID: 8435897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parenteral bromocriptine in the treatment of hormonally active pituitary tumours.
    Benker G; Gieshoff B; Freundlieb O; Windeck R; Schulte HM; Lancranjan I; Reinwein D
    Clin Endocrinol (Oxf); 1986 May; 24(5):505-13. PubMed ID: 3791649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid regression of pituitary prolactinomas during bromocriptine treatment.
    Thorner MO; Martin WH; Rogol AD; Morris JL; Perryman RL; Conway BP; Howards SS; Wolfman MG; MacLeod RM
    J Clin Endocrinol Metab; 1980 Sep; 51(3):438-45. PubMed ID: 6773972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue kallikrein and the effect of bromocriptine in human prolactin and growth hormone-secreting pituitary adenomas.
    Jones TH; Figueroa CD; Smith CM; Bhoola KD
    Agents Actions Suppl; 1992; 38 ( Pt 2)():175-82. PubMed ID: 1462825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and pathological effects of bromocriptine on prolactin-secreting and other pituitary tumors.
    Barrow DL; Tindall GT; Kovacs K; Thorner MO; Horvath E; Hoffman JC
    J Neurosurg; 1984 Jan; 60(1):1-7. PubMed ID: 6689702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactin-secreting macroadenomas in adolescents. Response to bromocriptine therapy.
    Tyson D; Reggiardo D; Sklar C; David R
    Am J Dis Child; 1993 Oct; 147(10):1057-61. PubMed ID: 8213676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic treatment of acromegaly: different effects on hormone secretion and tumor size.
    Oppizzi G; Liuzzi A; Chiodini P; Dallabonzana D; Spelta B; Silvestrini F; Borghi G; Tonon C
    J Clin Endocrinol Metab; 1984 Jun; 58(6):988-92. PubMed ID: 6725515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.